Pharmafile Logo

vector pharma

vector pharma specialises in the provision of close strategic regulatory support to innovative small to medium-size development-phase pharma companies seeking product approval within the EU. vector pharma works very closely with clients on a limited number of projects. Before taking on a contract we will discuss your requirements in detail. If we consider that a project is not appropriate for our resources or expertise we will tell you so.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

2 Victoria Road, Harpenden, Hertfordshire, AL5 4EA, United Kingdom
+44 (0)1582 761266

 Latest Content from PMHub 

A Lucid Group Thirsty Thursday: change management and self-efficacy

Last week, Lucid Group were lucky enough to have Richard Nugent, Founder and Managing Director of TwentyOne Leadership, present a session on change management and self-efficacy. Richard often works with...

Lucid Group expand its UK office footprint in Macclesfield

Lucid Group is increasing its share of office space on the popular Tytherington Business Village, after a sustained period of growth, which has seen it outperform a buoyant marketplace and taken...

How does nature influence wellbeing and refocus the mind?

Time is the 21st century's most precious commodity – we all live in a world where rushing around seems more normal than having a relaxing coffee break

Article

White Papers and Resources | October 30, 2020 | Inizio

How will COVID-19 affect uptake of vaccinations against other diseases?

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Podcast

White Papers and Resources | October 30, 2020 | Inizio

Living With Chronic Illness (Series one)

How to make an impact at a virtual congress

As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. Rather than trying to replicate the in-person congress experience, the industry has a real...

Webcast

White Papers and Resources | October 30, 2020 | Inizio

China: How pharma can maximize success in this rapidly changing emerging market

The Unknown Unknowns

Press Releases | October 30, 2020 | Resonant Group

Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma...